KELLY KOEHLER: Open Payments
NPI 1003480179 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 25 payments from 5 companies in 2025. Trend: 2023 $377 · 2024 $143 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $223 |
| Otsuka America Pharmaceutical, Inc. | 8 | $175 |
| Alkermes, Inc. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
Products named: VRAYLAR, REXULTI, ARISTADA, LEQVIO, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, AVYCAZ.
Industry payments across NV — which companies pay providers there.
